RE: Asset value versus SP .15 Jun 2023 12:28
Said it before, the LFT saga has obviously no relevance at all in any way shape or form, other than taking advantage at the time to raise funds for Tx. That cash got AVA6k in the clinic. It’s an entirely separate division with no different leadership. Trying to draw conclusions on an ongoing clinical trial and an apparent ’delay’ equating to impending doom is absolute nonsense, unbelievably stupid and pure FUD.
The reason there’s no news on the trial is simple. There is no news yet. They’ll update as it progresses as they have done with every single other cohort. The delay is likely due to a DLT and another 3 altruistic people volunteering. That’s all there is to it. It’s impossible for this pathetic FUD to hold any truth - apparent ’delays’ don’t equate to bad news, the results to date suggest the opposite. The trial is taking longer as it’s working better than expected. The next steps are either another DE, great news for the safety of the platform and gaining more data or we move to phase 1b, great news as we’re closer to efficacy data.